Signant Health Executive and Leadership Team

Bonner Jordan, the Director of Executive Operations, Office of the Chief Executive Officer at Signant Health, manages the strategic workflow and administrative priorities for the executive leadership team. Coordinating high-level initiatives, the Director of Executive Operations, Office of the Chief Executive Officer ensures that corporate objectives align with the broader mission of providing advanced eCOA and IRT software solutions. Bonner Jordan facilitates communication between the Board and internal departments to maintain operational momentum. By streamlining internal processes, the Director of Executive Operations, Office of the Chief Executive Officer supports the rapid deployment of clinical trial technologies across North American and European markets. This role requires constant oversight of organizational health and the execution of critical business projects. Through meticulous planning and cross-functional collaboration, the Director of Executive Operations, Office of the Chief Executive Officer drives efficiency, ensuring that the executive office remains focused on long-term growth and innovation within the competitive health software landscape.

Krishna Maridi, the Chief Financial Officer at Signant Health, directs the global financial strategy and fiscal planning for the organization. Overseeing capital allocation and investment in eCOA and data analytics platforms, the Chief Financial Officer ensures the company maintains a strong balance sheet to support ongoing research and development. Krishna Maridi manages financial reporting, risk assessment, and long-term budgeting to sustain market leadership in the clinical trial software sector. By analyzing revenue streams from remote and site-based solutions, the Chief Financial Officer optimizes resource distribution across international operations. This leadership position involves close collaboration with the Board to evaluate acquisition opportunities and organic growth initiatives. Through rigorous financial oversight, the Chief Financial Officer secures the necessary funding to scale infrastructure and expand the reach of software offerings. Maridi maintains fiscal discipline, ensuring that every investment directly contributes to the advancement of clinical trial efficiency and overall corporate profitability.

Graciela Racaro, the Chief Operating Officer at Signant Health, manages the internal business operations and service delivery models for the company's software solutions. Overseeing the implementation of eCOA and IRT platforms, the Chief Operating Officer ensures that client projects meet strict timelines and quality standards. Graciela Racaro optimizes operational workflows to improve efficiency in remote and site-based clinical trial support. By coordinating cross-departmental efforts, the Chief Operating Officer aligns service delivery with the company's strategic goals for global expansion. This role involves monitoring performance metrics and refining processes to enhance customer satisfaction and retention. Through the management of complex supply chain and data analytics operations, the Chief Operating Officer supports the seamless execution of clinical trials. Racaro drives operational excellence by fostering a culture of accountability and continuous improvement. The Chief Operating Officer ensures that the organization remains agile, capable of scaling operations to meet the increasing demand for digital clinical trial tools across international markets.

Ed Pollack, the Chief Technology Officer at Signant Health, architects the technical roadmap for the company's suite of eCOA, eConsent, and IRT software solutions. Leading the engineering and product development teams, the Chief Technology Officer drives innovation in data analytics and remote clinical trial platforms. Ed Pollack ensures that all software architecture meets stringent regulatory standards while providing seamless user experiences for global research sites. By integrating advanced cloud infrastructure, the Chief Technology Officer scales the platform to handle complex supply chain management and real-time data processing. This role involves constant evaluation of emerging technologies to maintain a competitive edge in the health software market. Pollack collaborates with other C-suite leaders to align technical capabilities with evolving customer needs. Through the implementation of robust security protocols and scalable codebases, the Chief Technology Officer guarantees the reliability and performance of the entire digital ecosystem, ultimately supporting the successful execution of clinical trials worldwide.

Scott Connor, the Chief Marketing Officer at Signant Health, directs the global brand strategy and market positioning for the company's clinical trial software portfolio. Overseeing demand generation and corporate communications, the Chief Marketing Officer builds awareness for eCOA, eConsent, and IRT solutions among pharmaceutical and biotech clients. Scott Connor analyzes market trends to identify growth opportunities across diverse geographic regions, ensuring that the value proposition resonates with clinical research stakeholders. By managing digital marketing campaigns and industry partnerships, the Chief Marketing Officer expands the company's footprint in the competitive health technology space. This leadership role requires close coordination with the sales and product teams to ensure consistent messaging and effective lead conversion. Through data-driven marketing initiatives, the Chief Marketing Officer drives brand equity and customer acquisition. Connor maintains a focus on demonstrating the tangible impact of software solutions on clinical trial outcomes, thereby strengthening the market position and supporting long-term revenue growth.

Roopal Patel, the Senior Vice President of Biotech and Chief Revenue Officer Portfolio Delivery at Signant Health, directs the revenue strategy and client engagement for the biotech sector. Overseeing the delivery of the entire software portfolio, the Senior Vice President of Biotech and Chief Revenue Officer Portfolio Delivery ensures that client needs are met with tailored eCOA and IRT solutions. Roopal Patel manages the sales pipeline and contract negotiations to drive consistent revenue growth across the biotech market. By aligning portfolio delivery with specific customer requirements, the Senior Vice President of Biotech and Chief Revenue Officer Portfolio Delivery maximizes the value provided to clinical research organizations. This role involves close collaboration with the product and operations teams to ensure that service delivery remains high-quality and scalable. Through strategic account management and market expansion, the Senior Vice President of Biotech and Chief Revenue Officer Portfolio Delivery secures long-term partnerships. Patel drives revenue performance by focusing on the unique challenges faced by biotech firms in the clinical trial landscape.